Shanghai Pharma IPO yields $2B

Shanghai Pharmaceuticals wrapped up its IPO in Hong Kong at a price of HK$23 per share, or almost $2 billion total. Pfizer was a key investor with $50 million in the deal. The stock will start trading on Friday. Report